Testing effectiveness (Phase 2)Study completedNCT02969525
What this trial is testing
Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis
Who this might be right for
Psoriatic Arthritis
UCB Biopharma S.P.R.L. 206